Predictors of referral for adjuvant therapy for colorectal cancer

Canadian Journal of Surgery

Volumn 48, Issue 3, 2005, Pages 225-229

  Ong, Sharon ^a,d   Watters, James M ^a,b   Grunfeld, Eva ^a,b,c   O'Rourke, Keith ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c OTTAWA REGIONAL CANCER CENTRE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANADA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; COMORBIDITY; FEMALE; HUMAN; MALE; MEDICAL DECISION MAKING; ONCOLOGY; PATIENT REFERRAL; PRACTICE GUIDELINE; RECTUM CANCER; RETROSPECTIVE STUDY; SEX DIFFERENCE;

AGED; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COMORBIDITY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 21344442876     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-50.
2. Figueredo A, Fine S, Maroun J, Walker-Dilks C, Wong S, and the Gastrointestinal Cancer Disease Site Group. Adjuvant therapy for stage III colon cancer following complete resection. Cancer Prev Control 1997;1:304-19.
3. Figueredo A, Germond C, Taylor B, Maroun J, Agboola O, Wong R, et al. Postoperative adjuvant radiotherapy and/or chemotherapy for resected stage II or III rectal cancer. Available: www.cancer care.on.ca/access_1105.htm (accessed 2005 Apr 5).
4. Beart RW, Steele GD Jr, Menck HR, Chmiel JS, Ocwieja KE, Winchester DP. Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. J Am Coll Surg 1995;181:225-36.
5. Tropman SE, Hatzell T, Paskett E, Ricketts T, Cooper MR, Aldrich T. Colon cancer treatment in rural North and South Carolina. Cancer Detect Prev 1999;23:428-34.
6. Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The National Cancer Data Base Report on Colon Cancer. Cancer 1996;78:18-26.
7. Roetzheim R, Pal N, Gonzalez E, Ferrante J, Van Durme D, Krischer J. Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health 2000;90:1746-54.
8. Ayanian JZ, Zaslavsky AM, Fuchs CS, Guadagnoli E, Creech CM, Cress RD, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 2003;21:1293-300.
9. Charlson ME, Ales KA, Pompei P, Mackenzie CR. A new method of classification of prognostic comorbidity for longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
10. Charlson ME, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47: 1245-51.
11. Cancer Guidance Sub-Group of the Clinical Outcomes Group. Improving outcomes in colorectal cancer: the research evidence. London: NHS Executive, Department of Health; 1997.
12. Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 2001; 93:501-15.
13. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 2002;20:1192-202.
14. Midgley R, Kerr D. ABC of colorectal cancer: adjuvant therapy. BMJ 2000;321: 1208-11.
15. Ward JE, Gattellari M, Soloman MJ. Management of patients with colorectal cancer. Do Australian surgeons know the scientific evidence? Arch Surg 2002;137: 1389-94.
16. Woolf S, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999;318:527-30.
17. Grimshaw J, Russell I. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317-22.
18. Smith TJ, Hillner BE. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol 2001;19:2886-97.
19. Walter LC, Davidowitz NP, Heineken PA, Covinsky KE. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA 2004;291:2466-70.
20. Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, Haller DG, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001;345:1091-7.
21. Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 2002;136:349-57.
22. Neugut AI, Fleischauer AT, Sundararajan V, Mitra N, Heitjan DF, Jacobson JS, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol 2002;20:2643-50.
23. Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 2002;20:3992-8.
24. Extermann M, Balducci L, Lyman GH. What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol 2000;18:1709-17.
25. Watters JM, McClaran JC. Perioperative management of the elderly patient. In: Wilmore DW, Cheung LY, Harken AH, Holcroft JW, Meakins JL, editors. ACS surgery: principles and practice. New York: WebMD; 2002.